The Venous Thromboembolism (VTE) Treatment Market is projected to grow at a CAGR of 7.2% from 2023 to 2030, reaching $4.40 billion by 2030. This growth is primarily driven by the high prevalence of venous thromboembolism,
The Venous Thromboembolism Treatment Market is expected to grow at a CAGR of 7.2% from 2023 to 2030 to reach $4.40 billion by 2030. The growth of this market is mainly driven by the high prevalence of venous thromboembolism, rising